A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
University of Chicago
University of Chicago
Medical University of South Carolina
NRG Oncology
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Oklahoma
Emory University
Stanford University
Henry Ford Health System
Centre Francois Baclesse
JS InnoPharm, LLC
Sunnybrook Health Sciences Centre
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Charite University, Berlin, Germany
Thomas Jefferson University
Mitra RxDx, Inc.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Queensland Centre of Excellence for Head and Neck Cancer